Literature DB >> 22371876

Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

Daniel H Solomon1, Maura D Iversen, Jerry Avorn, Timothy Gleeson, M Alan Brookhart, Amanda R Patrick, Laura Rekedal, William H Shrank, Joyce Lii, Elena Losina, Jeffrey N Katz.   

Abstract

BACKGROUND: Multiple studies demonstrate poor adherence to medication regimens prescribed for chronic illnesses, including osteoporosis, but few interventions have been proven to enhance adherence. We examined the effectiveness of a telephone-based counseling program rooted in motivational interviewing to improve adherence to a medication regimen for osteoporosis.
METHODS: We conducted a 1-year randomized controlled clinical trial. Participants were recruited from a large pharmacy benefits program for Medicare beneficiaries. All potentially eligible individuals had been newly prescribed a medication for osteoporosis. Consenting participants were randomized to a program of telephone-based counseling (n = 1046) using a motivational interviewing framework or a control group (n = 1041) that received mailed educational materials. Medication regimen adherence was the primary outcome compared across treatment arms and was measured as the median (interquartile range) medication possession ratio, calculated as the ratio of days with filled prescriptions to total days of follow-up.
RESULTS: The groups were balanced at baseline, with a mean age of 78 years; 93.8% were female. In an intention-to-treat analysis, median adherence was 49% (interquartile range, 7%-88%) in the intervention arm and 41% (2%-86%) in the control arm (P = .07, Kruskal-Wallis test). There were no differences in self-reported fractures.
CONCLUSION: In this randomized controlled trial, we did not find a statistically significant improvement in adherence to an osteoporosis medication regimen using a telephonic motivational interviewing intervention.

Entities:  

Mesh:

Year:  2012        PMID: 22371876      PMCID: PMC3905804          DOI: 10.1001/archinternmed.2011.1977

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  25 in total

Review 1.  Bisphosphonates for osteoporosis.

Authors:  Murray J Favus
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 91.245

2.  The complex relation between bisphosphonate adherence and fracture reduction.

Authors:  Amanda R Patrick; M Alan Brookhart; Elena Losina; John T Schousboe; Suzanne M Cadarette; Helen Mogun; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

3.  The implications of therapeutic complexity on adherence to cardiovascular medications.

Authors:  Niteesh K Choudhry; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; William H Shrank
Journal:  Arch Intern Med       Date:  2011-05-09

Review 4.  Impact of osteoporosis treatment adherence on fracture rates in North America and Europe.

Authors:  Ethel S Siris; Peter L Selby; Kenneth G Saag; Fredrik Borgström; Ron M C Herings; Stuart L Silverman
Journal:  Am J Med       Date:  2009-02       Impact factor: 4.965

Review 5.  Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials.

Authors:  M M Wilkes; R J Navickis; W W Chan; E M Lewiecki
Journal:  Osteoporos Int       Date:  2009-07-02       Impact factor: 4.507

6.  Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007.

Authors:  Jeanne M Madden; Amy J Graves; Dennis Ross-Degnan; Becky A Briesacher; Stephen B Soumerai
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

7.  Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.

Authors:  Jeffrey R Curtis; Andrew O Westfall; Hong Cheng; Kenneth Lyles; Kenneth G Saag; Elizabeth Delzell
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

8.  A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial.

Authors:  D H Solomon; T Gleeson; M Iversen; J Avorn; M A Brookhart; J Lii; E Losina; F May; A Patrick; W H Shrank; J N Katz
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

9.  A practice-based trial of motivational interviewing and adherence in hypertensive African Americans.

Authors:  Gbenga Ogedegbe; William Chaplin; Antoinette Schoenthaler; David Statman; David Berger; Tabia Richardson; Erica Phillips; Jacqueline Spencer; John P Allegrante
Journal:  Am J Hypertens       Date:  2008-07-24       Impact factor: 2.689

10.  Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?

Authors:  William H Shrank; Suzanne M Cadarette; Emily Cox; Michael A Fischer; Jyotsna Mehta; Alan M Brookhart; Jerry Avorn; Niteesh K Choudhry
Journal:  Med Care       Date:  2009-03       Impact factor: 2.983

View more
  37 in total

Review 1.  Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.

Authors:  Elisabeth Lilian Pia Sattler; Jung Sun Lee; Matthew Perri
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

Review 2.  Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.

Authors:  M Hiligsmann; M Salas; D A Hughes; E Manias; F H Gwadry-Sridhar; P Linck; W Cowell
Journal:  Osteoporos Int       Date:  2013-05-01       Impact factor: 4.507

Review 3.  Telephone-based motivational interviewing for medication adherence: a systematic review.

Authors:  Benjamin S Teeter; Jan Kavookjian
Journal:  Transl Behav Med       Date:  2014-12       Impact factor: 3.046

Review 4.  Motivational Interviewing Improves Medication Adherence: a Systematic Review and Meta-analysis.

Authors:  Ana Palacio; Desiree Garay; Benjamin Langer; Janielle Taylor; Barbara A Wood; Leonardo Tamariz
Journal:  J Gen Intern Med       Date:  2016-05-09       Impact factor: 5.128

5.  Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.

Authors:  A Shah; D Prieto-Alhambra; S Hawley; A Delmestri; J Lippett; C Cooper; A Judge; M K Javaid
Journal:  Osteoporos Int       Date:  2016-11-03       Impact factor: 4.507

6.  Motivational interviewing to improve self-care for patients with chronic heart failure: MITI-HF randomized controlled trial.

Authors:  Ruth Masterson Creber; Megan Patey; Christopher S Lee; Amy Kuan; Corrine Jurgens; Barbara Riegel
Journal:  Patient Educ Couns       Date:  2015-08-29

Review 7.  Improving drug adherence in osteoporosis: an update on more recent studies.

Authors:  Ayesha Jaleel; Kenneth G Saag; Maria I Danila
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-07-10       Impact factor: 5.346

8.  Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.

Authors:  Ieva Ruza; Sasan Mirfakhraee; Eric Orwoll; Ugis Gruntmanis
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

9.  A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.

Authors:  Manel Pladevall; George Divine; Karen E Wells; Ken Resnicow; L Keoki Williams
Journal:  Diabetes Educ       Date:  2014-12-08       Impact factor: 2.140

10.  Patient characteristics associated with medication adherence.

Authors:  Sharon J Rolnick; Pamala A Pawloski; Brita D Hedblom; Stephen E Asche; Richard J Bruzek
Journal:  Clin Med Res       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.